Magnetic Field Application in Patellofemoral Pain Syndrome

December 2, 2024 updated by: KTO Karatay University

Investigating the Effect of Magnetic Field Application Used in Patellofemoral Pain Syndrome

The purpose of this study is to examine the effect of magnetic field application used in the treatment of patellofemoral pain.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The aim of this randomized controlled study is to examine the effect of magnetic field application used in the treatment of patellofemoral pain.

The main question it aims to answer is;

Is magnetic field therapy applied in addition to conventional treatment effective in reducing pain in individuals with Patellofemoral pain syndrome?

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Konya, Turkey
        • KTO Karatay University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Having been diagnosed with patellofemoral pain syndrome by an orthopedic physician
  • Volunteering to participate in the study
  • Having pain for more than eight weeks
  • Patients who did not undergo surgery

Exclusion Criteria:

  • Patients diagnosed with rheumatological disease
  • Patients who have previously had steroid injections in the knee area
  • Patients with entrapment neuropathy and deformity in the lower extremity
  • Patients who are pregnant
  • Patients suffering from scoliosis,
  • Patients who use non-steroidal anti-inflammatory and antidepressant regularly for any reason

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control Group
Conventional treatment
Other: Conventional treatment
Within the scope of conventional treatment, hotpack application, transcutaneous electrical stimulation (TENS), interferential current and ultrasound treatment modalities will be applied. In addition, strengthening exercises will be applied to the muscles around the hip and knee and stretching exercises will be applied to the short muscle groups.
Experimental: Study Group
Conventional treatment+ Magnetic field application
Device: Magnetic field application
The applicator (Size: 15x15 cm) has placed 1-3 cm above the skin surface at the painful area. During the treatment, treatment has applied with ready-made protocols included in the device.
Other: Conventional treatment
Within the scope of conventional treatment, hotpack application, transcutaneous electrical stimulation (TENS), interferential current and ultrasound treatment modalities will be applied. In addition, strengthening exercises will be applied to the muscles around the hip and knee and stretching exercises will be applied to the short muscle groups.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analogue Scale (VAS)
Time Frame: The evaluation will be applied at the beginning of the treatment program.
A Visual Analogue Scale (VAS) is one of the pain rating scales.Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain.
The evaluation will be applied at the beginning of the treatment program.
36-Item Short Form Survey (SF-36)
Time Frame: The evaluation will be applied at the beginning of the treatment program.
The SF-36 is a 36-item self-report measure of health-related quality of life. It has eight subscales measuring different domains of health-related quality of life: physical functioning (PF), role-physical (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role-emotional (RE), and mental health (MH).
The evaluation will be applied at the beginning of the treatment program.
Manual Muscle Test
Time Frame: The evaluation will be applied at the beginning of the treatment program.
Manual muscle testing is based on the physiotherapist manually applying resistance to the muscle or muscle group to be evaluated.
The evaluation will be applied at the beginning of the treatment program.
The Lower Extremity Functional Scale (LEFS)
Time Frame: The evaluation will be applied at the beginning of the treatment program.
The Lower Extremity Functional Scale (LEFS) is a questionnaire containing 20 questions about a person's ability to perform everyday tasks. The LEFS can be used by clinicians as a measure of patients' initial function, ongoing progress and outcome, as well as to set functional goals.
The evaluation will be applied at the beginning of the treatment program.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

KTO Karatay University

Investigators

  • Study Chair: Osman Karaca, PhD, KTO Karatay University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2024

Primary Completion (Actual)

June 30, 2024

Study Completion (Actual)

October 24, 2024

Study Registration Dates

First Submitted

February 26, 2024

First Submitted That Met QC Criteria

February 26, 2024

First Posted (Actual)

March 1, 2024

Study Record Updates

Last Update Posted (Estimated)

December 4, 2024

Last Update Submitted That Met QC Criteria

December 2, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • KaratayUOAS

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain, Knee

Clinical Trials on Magnetic field application

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uganda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe